Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 2 de 2
Filter
Add more filters

Database
Language
Affiliation country
Publication year range
1.
Mol Pharm ; 17(2): 472-487, 2020 02 03.
Article in English | MEDLINE | ID: mdl-31789523

ABSTRACT

The colloidal stability, in vitro toxicity, cell association, and in vivo pharmacokinetic behavior of liposomes decorated with monomethoxy-poly(ethylene glycol)-lipids (mPEG-lipids) with different chemical features were comparatively investigated. Structural differences of the mPEG-lipids used in the study included: (a) surface-anchoring moiety [1,2-distearoyl-sn-glycero-3-phosphoethanolamine (DSPE), cholesterol (Chol), and cholane (Chln)]; (b) mPEG molecular weight (2 kDa mPEG45 and 5 kDa mPEG114); and (c) mPEG shape (linear and branched PEG). In vitro results demonstrated that branched (mPEG114)2-DSPE confers the highest stealth properties to liposomes (∼31-fold lower cell association than naked liposomes) with respect to all PEGylating agents tested. However, the pharmacokinetic studies showed that the use of cholesterol as anchoring group yields PEGylated liposomes with longer permeance in the circulation and higher systemic bioavailability among the tested formulations. Liposomes decorated with mPEG114-Chol had 3.2- and ∼2.1-fold higher area under curve (AUC) than naked liposomes and branched (mPEG114)2-DSPE-coated liposomes, respectively, which reflects the high stability of this coating agent. By comparing the PEGylating agents with same size, namely, linear 5 kDa PEG derivatives, linear mPEG114-DSPE yielded coated liposomes with the best in vitro stealth performance. Nevertheless, the in vivo AUC of liposomes decorated with linear mPEG114-DSPE was lower than that obtained with liposomes decorated with linear mPEG114-Chol. Computational molecular dynamics modeling provided additional insights that complement the experimental results.


Subject(s)
Cholanes/administration & dosage , Cholesterol/administration & dosage , Drug Carriers/pharmacokinetics , Phosphatidylethanolamines/administration & dosage , Polyethylene Glycols/administration & dosage , Animals , Biological Availability , Cholanes/chemistry , Cholanes/pharmacokinetics , Cholesterol/chemistry , Cholesterol/pharmacokinetics , Drug Compounding/methods , Drug Stability , HeLa Cells , Humans , Lipids , Liposomes , Mice , Mice, Inbred BALB C , Molecular Dynamics Simulation , Molecular Weight , Phosphatidylethanolamines/chemistry , Phosphatidylethanolamines/pharmacokinetics , Polyethylene Glycols/chemistry , Polyethylene Glycols/pharmacokinetics , Surface Properties
SELECTION OF CITATIONS
SEARCH DETAIL